procarbazine and Minimal Disease, Residual
procarbazine has been researched along with Minimal Disease, Residual in 8 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Based on the treatment results of 300 Hodgkin lymphoma patients the authors formulated the basic approaches for radiation treatment in ABVD and BEACOPP-21 chemotherapy regimens recipients." | 1.38 | [The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma]. ( Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM, 2012) |
"Of the 13 children with a residual tumour, chemotherapy induced 2 partial responses (PR), 1 minor response (MR) and 1 stable disease (SD) with no recurrent disease." | 1.33 | High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. ( Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA, 2006) |
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Datsenko, PV | 1 |
Pan'shin, GA | 1 |
Sotnikov, VM | 1 |
Ivashin, AV | 1 |
Evstikheev, ÉV | 1 |
Golub, SV | 1 |
Gombolevskiĭ, VA | 1 |
Kriz, J | 2 |
Reinartz, G | 1 |
Dietlein, M | 2 |
Kobe, C | 2 |
Kuhnert, G | 1 |
Haverkamp, H | 1 |
Haverkamp, U | 1 |
Engenhart-Cabillic, R | 1 |
Herfarth, K | 1 |
Lukas, P | 1 |
Schmidberger, H | 1 |
Staar, S | 2 |
Hegerfeld, K | 1 |
Baues, C | 1 |
Engert, A | 3 |
Eich, HT | 3 |
Vigneron, C | 1 |
Antoni, D | 1 |
Coca, A | 1 |
Entz-Werlé, N | 1 |
Lutz, P | 1 |
Spiegel, A | 1 |
Jannier, S | 1 |
Niederst, C | 1 |
Jarnet, D | 1 |
Meyer, P | 1 |
Kehrli, P | 1 |
Noël, G | 1 |
Franklin, J | 1 |
Markova, J | 1 |
Lohri, A | 1 |
Amthauer, H | 1 |
Klutmann, S | 1 |
Knapp, WH | 1 |
Zijlstra, JM | 1 |
Bockisch, A | 1 |
Weckesser, M | 1 |
Lorenz, R | 1 |
Schreckenberger, M | 1 |
Bares, R | 1 |
Mueller, RP | 1 |
Fuchs, M | 1 |
Borchmann, P | 1 |
Schicha, H | 1 |
Diehl, V | 2 |
Chintagumpala, MM | 1 |
Friedman, HS | 1 |
Stewart, CF | 1 |
Kepner, J | 1 |
McLendon, RE | 1 |
Modrich, PL | 1 |
McCluggage, C | 1 |
Burger, P | 1 |
Holmes, E | 1 |
Thompson, S | 1 |
Rutka, J | 1 |
Michalski, J | 1 |
Woo, S | 1 |
Blaney, SM | 1 |
Kun, LE | 1 |
Horowitz, ME | 1 |
Dufour, C | 1 |
Grill, J | 1 |
Lellouch-Tubiana, A | 1 |
Puget, S | 1 |
Chastagner, P | 1 |
Frappaz, D | 1 |
Doz, F | 1 |
Pichon, F | 1 |
Plantaz, D | 1 |
Gentet, JC | 1 |
Raquin, MA | 1 |
Kalifa, C | 1 |
Gossmann, A | 1 |
Bredenfeld, H | 1 |
Hansemann, K | 1 |
Skripnitchenko, R | 1 |
Brillant, C | 1 |
Pfistner, B | 1 |
Müller, RP | 1 |
Redei, I | 1 |
Mangan, KF | 1 |
Ming, PL | 1 |
Mullaney, MT | 1 |
Rao, PN | 1 |
Goldberg, SL | 1 |
Klumpp, TR | 1 |
Trials
4 trials available for procarbazine and Minimal Disease, Residual
Article | Year |
---|---|
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph | 2015 |
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise | 2008 |
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Alkyl and Aryl Transferases; Antineoplastic | 2006 |
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 2007 |
Other Studies
4 other studies available for procarbazine and Minimal Disease, Residual
Article | Year |
---|---|
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin | 2012 |
[Pediatric medulloblastoma: Retrospective series of 52 patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adju | 2016 |
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisp | 2006 |
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An | 1997 |